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in Lanzhou, China (8). Variation may 
be due to different geographic and 
age distributions of the virus. Anoth-
er study reported that frequencies of 
WUPyV in URTIs (6.7%) and LRTIs 
cases (7.1%) were comparable (10). 
However, we found the incidence 
of WUPyV in patients with LRTIs 
(16.1%) was higher than in patients 
with URTIs (4.4%). Among WUPyV-
infected patients with LRTIs, 71.4% 
were <1 year of age, which was com-
parable to populations investigated in 
other studies (2,3,6). Although ≈60% 
of outpatients with URTIs were >5 
years of age, none was WUPyV posi-
tive. This fi nding suggests WUPyV 
may play a major role in young chil-
dren, especially infants, with LRTIs.
Most WUPyV infection has been 
detected during later winter and early 
spring (2,4,5) although other research 
showed no seasonal distribution (6). 
We found 2 peaks, in April and De-
cember 2008 (L. Xiaoyan et al., unpub. 
data). We also detected 1 WUPyV-in-
fected case in September 2008, which 
suggests WUPyV could also occur in 
summer months.
Frequency of WUPyV co-infec-
tion with other pathogens varied from 
42.1% to 79.7% (4–6). Although we 
showed a co-infection rate of 71.4%, 
there were 8 (28.6%) of 28 patients 
with respiratory illness in whose 
specimens we detected only 1 virus, 
WUPyV. No WUPyV was detected 
in samples from 43 control patients, 
whereas in patients with LRTIs and 
URTIs, infection rates were 16.1% 
and 4.4%, respectively. These fi nd-
ings suggest WUPyV may be a po-
tential pathogenic agent in children 
with acute respiratory tract infections. 
More comprehensive case–control in-
vestigations are needed to determine 
the association of WUPyV infections 
with respiratory diseases.
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To the Editor: Capillariasis is 
caused by the foodborne nematode 
Capillaria philippinensis. Infection 
causes severe diarrhea and protein loss 
resulting in dehydration, cachexia, 
and eventually death. Infected patients 
may also have borborygmi, abdominal 
pain, weight loss, anorexia, vomiting, 
and bipedal edema (1).
C. philippinensis was fi rst report-
ed in 1963 in Bacarra, Ilocos Norte 
Province in the northern Philippines 
(2). Since then, additional endemic 
foci of C. philippinensis have been 
identifi ed. The most recent focus is in 
Monkayo, Compostela Valley, in the 
southern Philippines (3). In the past 
several years, suspected unconfi rmed 
cases have been reported from Zam-
boanga del Norte Province in western 
Mindanao. In 1999, an epidemic of 
gastroenteritis in Piñan Municipality 
was reported; it resulted in 42 deaths. 
The schistosomiasis team of the De-
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partment of Health Regional Offi ce 
conducted stool examinations and sus-
pected the presence of Capillaria ova 
in symptomatic patients (4). In No-
vember 2007, several deaths caused 
by chronic diarrhea were reported in 
Siayan Municipality. These deaths 
were attributed to capillariasis, but 
their cause was never confi rmed (5).
In February 2008, we obtained 
205 stool specimens from residents of 
Katipunan who had a history of diar-
rhea of >2 weeks duration and abdom-
inal disturbance. These samples were 
processed by using the formalin–ether 
concentration technique (6) and ex-
amined by expert microscopists. One 
hundred fi fty-one (73.3%) persons 
were infected with >1 organism; 67 
(32.5%) had 1 parasitic infection and 
84 (40.8%) had multiple parasitic in-
fections. Ninety-one (44.2%) persons 
had >1 soil-transmitted helminth in-
fection, and 93 (45.2%) had >1 pro-
tozoan infection. Ten (4.9%) persons 
were confi rmed to have Capillaria 
infections. The distribution of organ-
isms observed is shown in the Table.
Among the 10 persons who had 
capillariasis, 8 were from Baran-
gay (smallest adminstrative region) 
Matam, 1 from Barangay Dabiak, and 
1 from Barangay Carupay, a nearby 
barangay. Six cases were in male pa-
tients and 4 were in female patients. 
Ages of infected persons ranged from 5 
to 54 years (mean 29.2 years, SD 17.1 
years). Three of the reported case-pa-
tients (a 5-year-old boy, an 8-year old 
boy, and a 48-year-old woman) were 
from the same household.
A total of 24 persons in Katipu-
nan were interviewed regarding his-
tory of capillariasis and their eating 
habits. Fourteen residents reported 
having eaten kinilaw (raw freshwater 
fi sh soaked in vinegar and garnished 
with salt, ginger, and lime). Seven of 
the persons interviewed had a diagno-
sis of capillariasis, and 6 had >1 rela-
tive with a diagnosis of capillariasis. 
All of the previously diagnosed case-
patients were treated with albendazole 
(400 mg tablets). Most patients were 
instructed to take 1 tablet 1×/day for 
20 days; others were instructed to take 
1 tablet 2×/day for 5 or 10 days.
The drug of choice for treating 
patients with capillariasis is mebenda-
zole, 200 mg 2×/day for 20–30 days. 
An alternative treatment is albenda-
zole, 400 mg 1×/day for 10 days (7,8). 
Variations in the treatment regimen 
used for patients with capillariasis at 
the study site suggest a need to train 
health professionals on the diagnosis, 
treatment, and follow-up of cases, and 
on disease prevention and control. 
Guidelines on proper laboratory tech-
niques for diagnosis of capillariasis; 
treatment protocols and supportive 
measures; and protocols for detection, 
follow-up, and treatment for relapse 
cases must be developed.
Rates of infection with protozoans 
and soil-transmitted helminths at the 
study site are high, which indicate fe-
cal contamination of food and water. A 
review of records from the Katipunan 
rural health unit indicated that 76% of 
households in this municipality have 
access to toilets. Only 11% of house-
holds have water connections (level 
III). Fifty-seven percent of households 
have access to communal faucets 
(level II), and 31% have access only 
to rivers or springs (9). Therefore, in-
creased access to toilets and safe water 
is needed. Local ordinances concern-
ing ownership and use of toilets must 
be strictly enforced, and evaluation 
and rehabilitation of existing toilet and 
water systems must be conducted.
In spite of efforts concerning in-
formation, education, and communi-
cation on capillariasis, many residents 
continue to eat raw or poorly cooked 
freshwater fi sh. Concurrent infection 
among household members, includ-
ing those in younger age groups, was 
observed in this study. These fi ndings 
result from the fact that consumption 
of kinilaw has become widely accept-
ed and is consumed as a viand (choice 
food) by families. Thus, information, 
education, and communication cam-
paigns must be intensifi ed. A promis-
ing approach is through collaboration 
with other agencies. For example, the 
Department of Education in the Philip-
pines may become involved in dissem-
ination of information on capillariasis 
to students and in early detection and 
treatment of infected school children.
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Table. Parasites detected in Katipunan, Zamboanga del Norte, the Philippines, 
February 2008* 
Parasite No. (%) 
Trichuris trichiura 64 (31.1) 
Entamoeba coli 49 (23.8) 
Ascaris lumbricoides 46 (22.3) 
Endolimax nana 14 (19.9) 
Hookworm 34 (16.5) 
Blastocystis hominis 21 (10.2) 
Giardia lamblia 19 (0.2) 
Entamoeba histolytica 14 (6.8) 
Capillaria philippinensis 10 (4.9) 
*A total of 205 parasites were detected by using the formalin–ether concentration technique. 
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To the Editor: Mycobacterium 
ulcerans disease (Buruli ulcer) is a 
neglected and emerging tropical dis-
ease (1). It often leads to extensive 
destruction of skin and soft tissue with 
the formation of large ulcers (2). In 
2004, the World Health Organization 
(WHO) recommended the combina-
tion treatment of rifampin/streptomy-
cin for patients with this disease (3). 
According to WHO, development of 
new antimicrobial drug treatment is 
one of the major advances since the 
establishment of the Global Buruli 
Ulcer Initiative (1). Treatment with 
rifampin/streptomycin for >4 weeks 
can inhibit the growth of M. ulcerans 
in preulcerative lesions (4). In other 
patients, despite 4 weeks of treatment, 
lesions may deteriorate. Whether this 
treatment is less effi cacious in persons 
with HIV infection is unknown.
In August 2008, a 35-year-old 
man was referred to the Medical Cen-
tre of the Democratic Republic of 
Congo for assessment of chronic ul-
cers. Lesions had appeared 12 months 
earlier when the patient was living in 
Kafufu/Luremo, a new focus of Buruli 
ulcer in Angola (5). Tissue specimens 
were subjected to Ziehl-Neelsen stain-
ing, culture, and PCR. All results were 
positive for M. ulcerans. Histopatho-
logic analysis of formalin-fi xed tissue 
confi rmed the diagnosis of active Bu-
ruli ulcer. We treated the patient with 
a combination of rifampin (10 mg/kg/
day, orally) and streptomycin (15 mg/
kg/day, by intramuscular injection). 
Wound dressings containing an aque-
ous solution of chloramine/metron-
idazole/nitrofurantoine were changed 
daily (6). For logistic reasons, surgery 
(large excision) under general anes-
thesia was not possible.
Characteristics of the patient are 
shown in the online Technical Appen-
dix (www.cdc.gov/EID/content/16/4/
738-Techapp.pdf). At the start of treat-
ment, the patient had a large ulcer on 
the right leg and thigh, a nodule 2 
cm in diameter on the left thigh, and 
a plaque 8 cm in diameter on the left 
thigh. After 2 weeks of treatment, the 
size of the large ulcer had increased. 
After 4 weeks, the nodule became an 
ulcer 6 cm in diameter, and the plaque 
became a large ulcer 15 cm in diameter 
with a satellite ulcer 2 cm in diameter. 
After 8 weeks, we observed enlarge-
ment of all lesions and the appearance 
of an ulcer on the left wrist. Treatment 
was continued for an additional 4 
weeks (total 12 weeks). Radiologic in-
vestigation did not disclose any bone 
destruction.
The patient was positive for HIV 
by the Determine HIV-1/2 test (Ab-
bott Laboratories, Dainabot Co. Ltd., 
Tokyo, Japan), the Uni-Gold HIV 
test (Trinity Biotech PLC, Bray, Ire-
land), and the Genie II HIV-1/HIV-2 
test (Bio-Rad, Marnes-la-Coquette, 
France). Results of PCR for M. ulcer-
ans and Ziehl-Neelsen staining were 
positive for all specimens obtained 
during the 8 weeks of initial treat-
ment. The patient died 2 weeks after 
treatment ended, just when antiretro-
viral treatment had been scheduled to 
begin.
Although the patient did not re-
spond clinically to treatment with 
rifampin/streptomycin, whether the 
treatment also failed microbiological-
ly is more diffi cult to prove. Results of 
PCRs performed during treatment re-
mained positive. However, PCR does 
not differentiate between living and 
dead M. ulcerans bacteria. Therefore, 
our positive results suggest, but do not 
prove, treatment failure. The positive 
culture after 2 weeks of treatment also 
suggests treatment failure but cultures 
obtained at 4 and 8 weeks were con-
taminated. However, culturing M. ul-
cerans bacteria is diffi cult, especially 
if samples must be transported (7).
Patients with Buruli ulcer may 
also be infected with HIV. In a study 
conducted during January 2002–Au-
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